Recombinant mouse beta-defensin 2 inhibits infection by influenza A virus by blocking its entry

Archives of Virology

Volumn 155, Issue 4, 2010, Pages 491-498

  Gong, Tianxiang ^a   Jiang, Yan ^a   Wang, Yueling ^a   Yang, De ^b   Li, Wanyi ^a   Zhang, Qiang ^a   Feng, Wei ^a   Wang, Baoning ^a   Jiang, Zhonghua ^a   Li, Mingyuan ^a,c  

^a SICHUAN UNIVERSITY   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

^c SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI; INFLUENZA A VIRUS; INFLUENZAVIRUS A; MUS; PROKARYOTA;

ANTIVIRUS AGENT; BETA DEFENSIN; DEFB2 PROTEIN, MOUSE; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL LINE; DOG; ESCHERICHIA COLI; FEMALE; GENE VECTOR; GENETICS; INFLUENZA VIRUS A; LUNG; MOUSE; ORTHOMYXOVIRUS INFECTION; PHYSIOLOGY; PLASMID; SURVIVAL; VIROLOGY; VIRUS ENTRY; VIRUS LOAD;

ANIMALS; ANTIVIRAL AGENTS; BETA-DEFENSINS; CELL LINE; DOGS; ESCHERICHIA COLI; FEMALE; GENETIC VECTORS; INFLUENZA A VIRUS; LUNG; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; PLASMIDS; RECOMBINANT PROTEINS; SURVIVAL ANALYSIS; VIRAL LOAD; VIRUS INTERNALIZATION;

EID: 77950605506     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-010-0608-1     Document Type: Article

References (24)

1. Selsted ME, Ouellettee AJ (2005) Mammalian defensins in the antimicrobial immune response. Nat Immunol 6: 551-557. doi: 10. 1038/ni206.
2. Lehrer R (2004) Primate defensins. Nat Rev Microbiol 2: 727-738. doi: 10. 1038/nrmicro976.
3. Lehrer RI, Ganz T (2002) Defensins of vertebrate animals. Curr Opin Immunol 14: 96-102. doi: 10. 10l6/S0952-7915(01)00303-X.
4. Yang D, Liu ZH, Tewary P et al (2007) Defensin participation in innate and adaptive immunity. Curr Pharm Des 13: 3131-3139. doi: 10. 2174/138161207782110453.
5. Pazgier M, Hoover DM, Yang D et al (2006) Human beta-defensins. Cell Mol Life Sci 63: 1294-1313. doi: 10. 1007/s00018-005-5540-2.
6. Moser C, Weiner DJ, Lysenko E et al (2002) β-defensin 1 contributes to pulmonary innate immunity in mice. Infect Immunol 70: 3068-3072. doi: 10. 1128/IAI. 70. 6. 3068-3072. 2002.
7. Bals R, Wang X, Meegalla RL et al (1999) Mouse β-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs. Infect Immunol 67: 3542-3547.
8. Jiang Y, Wang YL, Kuang Y et al (2009) Expression of mouse beta-defensin-3 in MDCK cells and its anti-influenza-virus activity. Arch Virol 154: 47-639. doi: 10. 1007/s00705-009-0352-6.
9. Morrison GM, Davidson DJ, Dorin JR (1999) A novel mouse beta defensin, Defb2, which is upregulated in the airways by lipopolysaccharide. FEBS Lett 442: 112-116. doi: 10. 1016/S0014-5793(98)01630-5.
10. Hussain T, Nasreen N, Lai YM et al (2008) Innate immune responses in murine pleural mesothelial cells: Toll-like receptor-2 dependent induction of beta-defensin-2 by Staphylococcal. Am J Physiol Lung Cell Physiol 295: 461-470. doi: 10. 1152/ajplung. 00276. 2007.
11. Schagger H, Von Jagow G (1987) Tricine-sodium dodecyl sulfatepolyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166: 368-379. doi: 10. 1016/0003-2697(87)90587-2.
12. Weiberg A, Krisanaprakornkit S, Dale BA (1998) Epithelial antimicrobial peptides: review and significance for oral applications. Crit Rev Oral Biol Med 9: 399-414. doi: 10. 1177/10454411980090040201.
13. Quinones-Mateu ME, Lederman MM, Feng Z et al (2003) Human epithelial beta-defensins 2 and 3 inhibit HIV-l replication. AIDS 17: 39-48. doi: 10. 1097/01. aids. 0000096878. 73209. 4f.
14. Pauwels R, Balzarini J, Baba M et al (1988) Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Methods 20: 309-321.
15. Sun X, Whittaker GR (2003) Role for influenza virus envelope cholesterol in virus entry and infection. J Virol 77: 12543-12551. doi: 10. 1128/JVI. 77. 23. 12543-12551. 2003.
16. Sinha S, Cheshenko N, Lehrer RI, Herold BC (2003) NP-1, a rabbit alpha defensin, prevents the entry and intracellular spread of herpes simplex virus type 2. Antimicrob Agents Chemother 47: 494-500. doi: 10. 1128/AAC. 47. 2. 494-500. 2003.
17. Jones JC, Turpin EA, Brandt CR et al (2006) Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells. J Virol 80: 11960-11967. doi: 10. 1128/JVI. 01678-06.
18. Hazrati E, Galen B, Lu W et al (2006) Human alpha and beta defensins block multiple steps in herpes simplex virus infection. J Immunol 177: 8658-8666.
19. Leikina E, Delanoe-Ayari H, Melikoy K et al (2005) Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat Immunol 6: 995-1001. doi: 10. 1038/ni1248.
20. Salvatore M, Garcia-Sastre A, Ruchala P et al (2007) alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism (s). J Infect Dis 196: 835-843. doi: 10. 1086/521027.
21. Chang TL, Vargas JJ, Del Portillo A et al (2005) Dual role of alpha-defensin-l in anti-HIV-1 innate immunity. J Clin Inves 115: 765-773. doi: 10. 1172/JCI21948.
22. Bessete PH, Aslund F, Beckwith J et al (1999) Efficient folding proteins with multiple disulfide bonds in the Escherichia coli cytoplasm. Proc Natl Acad Sci USA 96: 13703-13708.
23. La Valillie ER, Lu ZJ, Smith Diblasio et al (2000) Thioredoxin as a fusion partner for production of soluble recombinant proteins in Escherichia coli. Methods Enzymol 326: 322-340.
24. Piers KL, Brown MH, Hancock REW (1993) Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria. Gene 134: 7-13.